[HTML][HTML] Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from …

JT Sandberg, M Löfling, R Varnaitė… - PLOS Neglected …, 2023 - journals.plos.org
Background Flavivirus infections pose a significant global health burden underscoring the
need for the development of safe and effective vaccination strategies. Available flavivirus …

[HTML][HTML] Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination

V Bradt, S Malafa, A von Braun, J Jarmer… - npj Vaccines, 2019 - nature.com
Flaviviruses have an increasing global impact as arthropod-transmitted human pathogens,
exemplified by Zika, dengue, yellow fever (YF), West Nile, Japanese encephalitis, and tick …

Flaviviruses and flavivirus vaccines

FX Heinz, K Stiasny - Vaccine, 2012 - Elsevier
Several human-pathogenic flaviviruses (including yellow fever, dengue, Japanese
encephalitis, West Nile and tick-borne encephalitis viruses) have a significant public health …

Progress and works in progress: update on flavivirus vaccine development

MH Collins, SW Metz - Clinical therapeutics, 2017 - Elsevier
Most areas of the globe are endemic for at least one flavivirus, putting billions at risk for
infection. This diverse group of viral pathogens causes a range of manifestations in humans …

Yellow fever and Japanese encephalitis vaccines: indications and complications

AA Marfin, RSB Eidex, PE Kozarsky… - Infectious Disease …, 2005 - id.theclinics.com
Appropriate administration of yellow fever (YF) or Japanese encephalitis (JE) vaccines to
travelers requires an assessment of the traveler's risk for infection with these vector-borne …

[HTML][HTML] Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: a retrospective cohort study using three healthcare …

S Ledlie, C Ricci, C Pan, A Rojas, A Khromava, L Li - Vaccine, 2022 - Elsevier
Background Yellow fever (YF) vaccines are highly effective and have a well-established
safety profile despite the risk of rare serious adverse events (SAEs), vaccine-associated …

A chimeric Japanese encephalitis vaccine protects against lethal yellow fever virus infection without inducing neutralizing antibodies

N Mishra, R Boudewijns, MA Schmid, RE Marques… - MBio, 2020 - Am Soc Microbiol
Recent outbreaks of yellow fever virus (YFV) in West Africa and Brazil resulted in rapid
depletion of global vaccine emergency stockpiles and raised concerns about being …

Prior flavivirus immunity skews the yellow fever vaccine response to expand cross-reactive antibodies with increased risk of antibody dependent enhancement of Zika …

A Santos-Peral, F Luppa, S Goresch, E Nikolova… - bioRxiv, 2023 - biorxiv.org
Human pathogenic flaviviruses pose a significant health concern and vaccination is the most
effective instrument to control their circulation. How pre-existing immunity to antigenically …

[HTML][HTML] A perspective on current flavivirus vaccine development: a brief review

SK Dutta, T Langenburg - Viruses, 2023 - mdpi.com
The flavivirus genus contains several clinically important pathogens that account for
tremendous global suffering. Primarily transmitted by mosquitos or ticks, these viruses can …

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind …

PE Nasveld, J Marjason, S Bennett, J Aaskov… - Human …, 2010 - Taylor & Francis
A randomized, double-blind, study was conducted to evaluate the safety, tolerability and
immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) …